טוען...
DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells
BACKGROUND: 5-fluorouracil (5-FU)-based chemotherapy is the standard treatment for advanced stage colorectal cancer (CRC) patients. Several groups including ours have reported that stage II-III colorectal cancer patients whose tumors retain DNA Mismatch repair (MMR) function derive a benefit from 5-...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Landes Bioscience
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3367669/ https://ncbi.nlm.nih.gov/pubmed/21814034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.12.8.17169 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|